Select your country
Websites worldwide
Select a country to go to the website of the respective STADA sales company.
Australia (2)
Belarus (1)
Belgium (1)
Bosnia-Herzegovina (1)
Bulgaria (1)
China (1)
Croatia (1)
Czech Republic (2)
Denmark (1)
France (1)
Hungary (1)
Ireland (1)
Italy (1)
Montenegro (1)
Netherlands (2)
Poland (1)
Portugal (1)
Romania (1)
Saudi Arabia (1)
Serbia (1)
Slovakia (1)
Slovenia (1)
Spain (1)
Switzerland (1)
Thailand (1)
The Phillippines (1)
United Arab Emirates (1)
United Kingdom (3)
STADA and mAbxience enter into negotiations over Adalimumab biosimilar
STADA: Good result despite challenging framework conditions – Group sales rise by 4 percent – significant increase of adjusted EBITDA by 12 …
New STADA initiative investigates daily approach to health
STADA in-licenses teriparatide and further expands biosimilar portfolio
STADA plans to hand German logistics business over to a globally active and well-known logistics company
STADA: Solid result in difficult market environment – Group sales increase by 4 percent – adjusted key earnings figures substantially higher…
Interview with Chief Financial Officer Helmut Kraft on the occasion of the half-year results
STADA strengthens its branded product portfolio by purchasing the Flexitol® rights for UK and Ireland – a dermatological range in the area o…
STADA Executive Board shows satisfaction with financial year 2013 at Annual General Meeting and adheres to outlook for 2014
Three questions for Chairman of the Executive Board Hartmut Retzlaff
STADA subsidiary supports victims of Balkan flood
STADA with positive development in the first quarter of 2014 – Group sales rise by 7 percent – reported EBITDA and reported net income sligh…
STADA: Successful financial year 2013 – Adjusted EBITDA reaches new record high – Dividend to increase by 32 percent – 2014 outlook adjusted…
STADA: Preliminary figures show successful financial year 2013 – Dividend to increase by 32 percent – Outlook for 2014 confirmed
STADA: Successfully concluded purchase of the Russian branded product portfolio Aqualor® for the self-medication of sinusitis and sore throa…
STADA: Local insolvency administrator files lawsuit against a subsidiary of STADA Arzneimittel AG
STADA: Executive Board contract of Chief Financial Officer Helmut Kraft extended by four years